Shares of medical technology company Integer Holdings (NYSE:ITGR) fell 31.4% in the afternoon session after the company ...

Integer CEO Khales Payman bought 3,127 shares of the company's stock on Oct. 30, 2025. Mr. Payman purchased his company's stock on the day shares hit a 52-week low of $62.

Integer Holdings’ third quarter results were overshadowed by management’s acknowledgment of unexpected headwinds tied to ...

Medical technology company Integer Holdings (NYSE:ITGR) met Wall Street’s revenue expectations in Q3 CY2025, with sales up ...

Integer Holdings Corporation revises 2026 outlook, signaling flat growth. Click for potential ITGR investment opportunities ...

What Happened: Khales's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, involves purchasing 3,127 shares of Integer Holdings. The total ...

For the current year, Integer trimmed its outlook slightly. It now expects sales to rise 7% to 8%, versus its prior view of 8% to 9% growth, while adjusted earnings is now expected to be $6.29 to ...

The average one-year price target for Integer Holdings (NYSE:ITGR) has been revised to $95.30 / share. This is a decrease of ...

Integer Holdings announced today that Payman Khales has taken over the corner office at the medtech contract manufacturing ...

ITGR stock fell 48.7% from a high of $99.66 on July 29, 2021, to $51.11 on October 10, 2022, compared to a peak-to-trough ...

Continued strong sales and profit growth in 3Q25 ~~ Updating 2025 sales and profit outlook; providing preliminary outlooks for 2026 and 2027 ...